triazolam has been researched along with Pyrosis in 1 studies
Triazolam: A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Analyses of post-marketing surveillance and a database of all spontaneously reported adverse events were also evaluated." | 2.40 | The safety of ranitidine in over a decade of use. ( Fitzgerald, K; Koch, KM; Mills, JG; Sirgo, MA; Webster, C; Wood, JR, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mills, JG | 1 |
| Koch, KM | 1 |
| Webster, C | 1 |
| Sirgo, MA | 1 |
| Fitzgerald, K | 1 |
| Wood, JR | 1 |
1 review available for triazolam and Pyrosis
| Article | Year |
|---|---|
The safety of ranitidine in over a decade of use.
Topics: Anti-Ulcer Agents; Clinical Trials as Topic; Databases, Factual; Drug Interactions; Ethanol; Heartbu | 1997 |